| Name | Abingdon Health |
|---|---|
| Epic | ABDX |
| Isin | GB00BLF79J41 |
| Industry | Medical Equipment and Services |
| Latest share price | 6.25p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £12.10 | Debt ratio | n/a |
| Shares in issue | 193.63 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -48.11 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.42 | 52-week high / low | 5.25p / 8.68p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Abingdon Health |
|---|---|
| Address | York Biotech Campus, Sand Hutton, York, England, United Kingdom, YO41 1LZ |
| Telephone | +44 (0)1904 406082 |
| Website | http://www.abingdonhealth.com/ |
| Director | Position |
|---|---|
| Mr Katie Brenner | Non-Executive Director |
| Dr Christopher Hand | Executive Chairman |
| Ms Mary G Tavener | Senior Independent Non-Executive Director |
| Mr Tom Hayes | CFO & Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 30/06/24 | 30/06/23 | 30/06/22 |
| Intangible asssets and goodwill | 0.53 | 0.09 | 0.04 |
| Investments and other non-current assets | 0.01 | n/a | n/a |
| Total non-current assets | 1.54 | 1.35 | 1.81 |
| Inventory / work in progress | 0.44 | 0.33 | 0.53 |
| Trade and other receivables | 1.47 | 1.15 | 8.03 |
| Cash and equivalents | 1.44 | 3.24 | 2.4 |
| Other current assets and asset held for resale | 0.2 | 0.05 | n/a |
| Total of all assets | 5.09 | 6.11 | 12.77 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 1.82 | 2.12 | 5.32 |
| Long term liabilities | 1.02 | 1.02 | 1.01 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 2.84 | 3.14 | 6.34 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 2.25 | 2.97 | 6.43 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 0.08 | 0.08 | 0.08 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -28.76 | -27.49 | -24.11 |
| Share premium account | 30.81 | 30.31 | 30.31 |
| Total equity | 2.25 | 2.97 | 6.43 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -1.37 | -3.59 | -21.53 |
| Pre-tax profit | -1.4 | -3.57 | -21.59 |